Classic Hodgkin's Lymphoma
2 clinical trials · Condition
◉ Watch Classic Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL) (NCT05518318) | Guangzhou Gloria Biosciences Co., Ltd. | 2022-09-01 |
| A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy (NCT04044222) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-10-21 |
Track Classic Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.